#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    NTRK gene fusion overexpression Chronic graft versus host disease in intestine Fabry's disease Glycogen storage disease type V Parkinson's disease Pleomorphic liposarcoma Eosinophilic granulomatosis with polyangiitis Neuroendocrine carcinoma metastatic Oesophageal atresia B-cell small lymphocytic lymphoma recurrent Rhabdomyosarcoma recurrent Hypoparathyroidism Li-Fraumeni syndrome Leukaemia Ependymoma More trials…

    Learn about Rare Diseases

    Progressive supranuclear palsy – Treatment Retinoblastoma – Basic Information Encephalitis autoimmune – Trials in Disease Glomerulonephritis membranoproliferative – Treatment Phenylketonuria – Life with Disease Chordoma – Diagnostics Ewing’s sarcoma metastatic – Life with Disease Idiopathic pulmonary fibrosis – Basic Information Turner’s syndrome – Diagnostics Myelodysplastic syndrome with excess blasts More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amoxicillin Trihydrate LY3537031 Codeine Phosphate Hemihydrate Raxtozinameran CHLOROQUINE PHOSPHATE Aavanc80-5'Hotof Spironolactone Human Normal Immunoglobulin Human Immunoglobulin G Rgx-202 Nofazinlimab Semaglutide Nacubactam Holcus Lanatus Pollen Extract Vortioxetine Hydrobromide Tezacaftor Trastuzumab Emtansine Hyoscine ALPROSTADIL Eclitasertib More therapies…

    Learn about Your Condition

    Hip arthroplasty Microvillous inclusion disease Rasmussen encephalitis Tympanic membrane hyperaemia Myxoid liposarcoma Pancoast's tumour Synovial sarcoma metastatic Haemophilia Hypereosinophilic syndrome Ewing's sarcoma Urea cycle disorder Retinoblastoma Major depression Radius fracture Benign prostatic hyperplasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University General Hospital Of Thessaloniki Ahepa

University General Hospital Of Thessaloniki Ahepa

1st St Kiriakidis Str, Thessaloniki, 546 36, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease

    Not recruiting

    3 1
    Investigated Drugs:
    • BI 456906
    • SURVODUTIDE
    Austria Belgium Bulgaria Czechia Denmark Finland +11

  • Study on the Safety and Effects of PF-07868489 in Patients with Pulmonary Arterial Hypertension

    Not recruiting

    1 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • PF-07868489
    Belgium Czechia France Germany Greece Italy +1

  • Study on the Effectiveness and Safety of Frexalimab and Teriflunomide for Adults with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Austria Belgium Bulgaria Croatia Czechia Denmark +12

  • Study on Masitinib for Treating Primary or Secondary Progressive Multiple Sclerosis in Patients Without Relapse

    Not recruiting

    3 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Masitinib
    France Greece Poland Spain

  • Study Comparing Rosuvastatin and Fenofibrate with Pravastatin and Fenofibrate for Patients with Mixed Dyslipidemia at High Risk of Heart Disease

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Fenofibrate
    • Pravastatin Sodium
    • Rosuvastatin
    Greece

  • Study on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis

    Not recruiting

    3 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Frexalimab
    Belgium Bulgaria Czechia France Germany Greece +7

  • Study on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis

    Not recruiting

    3 1
    Investigated Drugs:
    • Tolebrutinib
    Austria Belgium Bulgaria Croatia Czechia Denmark +13

  • Study on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Multiple sclerosis relapse
    Investigated Drugs:
    • A/Darwin/6/2021(H3N2)-Like Strain (A/Darwin/11/2021, Wild Type)
    • A/Wisconsin/67/2022 (H1N1)Pdm09-Like Strain (A/Georgia/12/2022 Cvr-167)
    • B/Austria/1359417/2021-Like Strain (B/Singapore/Wuh4618/2021)
    Austria Belgium Bulgaria Croatia Czechia Denmark +15

  • Study Comparing the Effectiveness and Safety of Macitentan 75 mg and 10 mg for Patients with Pulmonary Arterial Hypertension

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Macitentan
    Austria Belgium Bulgaria Czechia Denmark France +10

  • Study comparing semaglutide with insulin glargine in overweight adults with type 2 diabetes: effectiveness of combined treatment versus insulin alone

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Overweight
    Investigated Drugs:
    • Insulin Glargine
    • Semaglutide
    Czechia Greece Italy Portugal Romania Slovakia +1
Previous Page
1 … 8 9 10 11 12 … 15
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!